Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

(2017) Jonathan Strosberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers

(2016) T. Vag et al.   JOURNAL OF NUCLEAR MEDICINE

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

(2015) K. Philipp-Abbrederis et al.   EMBO Molecular Medicine

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

(2015) Jiayu Chen et al.   Oncotarget

Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

(2015) Hans Jürgen Wester et al.   Theranostics

Current role of FDG PET/CT in lymphoma

(2014) Lale Kostakoglu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4

(2014) Takashi Nagasawa   JOURNAL OF MOLECULAR MEDICINE-JMM

PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand

(2011) Oliver Demmer et al.   ChemMedChem

PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent

(2011) E. Gourni et al.   JOURNAL OF NUCLEAR MEDICINE

Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy

(2010) Stefan E. Pool et al.   SEMINARS IN NUCLEAR MEDICINE